- Home
- Daily Diary
- Asset Class
- Sector
- Latest
- Author
- Street Notes
- TheStreet
- Switch to
+0.10| Last Update: 05/24/13 - 4:00 PM EDT |
| Volume: 348,499 |
| YTD Performance: 13.51% |
| Open: $22.12 |
| Previous Close: $22.18 |
| 52 Week Range: $15.38 - $31.03 |
| Oustanding Shares: 59,273,597 |
| Market Cap: 1,314,688,381 |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $0.15 | $0.19 | $0.65 | $0.84 |
| Number of Analysts | 7 | 7 | 7 | 8 |
| High Estimate | $0.18 | $0.24 | $0.75 | $1.05 |
| Low Estimate | $0.11 | $0.12 | $0.50 | $0.65 |
| Prior Year | $0.35 | $0.17 | $0.81 | $0.65 |
| Growth Rate (Year over Year) | -55.92% | 14.29% | -19.40% | 29.24% |
Adtran estimates, target boosted at JefferiesShares of ADTN now seen reaching $17.50, according to Jefferies. Estimates also upped, given the new AT&T deal. Underperform rating.
Adtran downgraded at MizuhoADTN was downgraded from Buy to Hold, Mizuho said. $18 price target. Recent checks suggest that the company lacks near-term catalysts.
ADTRAN downgraded at UBSADTN was downgraded to Sell from Neutral, UBS said. $17 price target. Visibility remains limited.
Adtran rated new Neutral at JP MorganCoverage of ADTN was started with a Neutral rating, JP Morgan said. $19 price target. Core business could continue to decline in 2013.
Adtran downgraded at CitigroupADTN was downgraded to Sell from Neutral, Citigroup said. $12.50 price target. Challenges in its mainstay wireline access franchise.
Adtran upgraded at MizuhoADTN was upgraded to Buy, Mizuho said. $22 price target. Business will likely bottom out in the fourth quarter.
ADTRAN numbers lowered at JefferiesShares of ADTN now seen reaching $13.25, Jefferies said. Estimates also lowered on ugly Q3. Underperform rating.
Adtran downgraded at Morgan StanleyADTN was downgraded from Equal-weight to Underweight, Morgan Stanley said. $12.50 price target. Estimates also cut, given weaker macro trends.
ADTRAN downgraded at UBSADTN was downgraded to Neutral from Buy, UBS said. $17 price target. Near term headwinds, limited visibility.